Back

Feasibility and safety of a 100% transfemoral approach for TAVI - a 4-year experience    

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Vascular complications in TAVI Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Filice

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

5 More presentations in this session

Presentation thumbnail
Vascular complications following TAVI: safety and predictors of the MANTA vascular closure device
Doctor T. Carlos (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Low femoral artery puncture for transfemoral TAVR
Doctor V. Jeyalan (Middlesbrough, GB)
Abstract Slides Video
Presentation thumbnail
Sex difference in characteristics and outcomes for transcatheter aortic valve implantation: a nationwide japanese study
Doctor K. Mitsui (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of complications after transcatheter aortic valve implantation (TAVI) according to VARC-3 criteria: a systematic review and meta-analysis
Doctor F. Giacobbe (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Does obesity impact outcomes in TAVI? A systematic review and meta-analysis
Mr L. Dexheimer Da Silva (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular complications in TAVI

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Transfemoral and transapical transcatheter aortic valve replacement for patients with aortic valve stenosis and peripheral artery disease in a German comparison
thumbnail
Congress Presentation
Insights into ultrasound-guided femoral puncture in transcatheter aortic valve replacement: analyzing vascular complications and mortality rates
thumbnail
Congress Presentation
Low femoral artery puncture for transfemoral TAVR

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources